Luke O'Neill
Director/Board Member at POOLBEG PHARMA PLC
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Matthew A. Cooper | M | - |
Inflazome Ltd.
 Inflazome Ltd. Pharmaceuticals: MajorHealth Technology Inflazome Ltd. engages in developing therapeutic medicines for inflammatory diseases. It manufactures and supplies medicines for muckle wells, type 2 diabetes, atherosclerosis, hypertension, gout, osteoarthritis, rheumatoid arthritis, Parkinson, Alzheimer, and multiple sclerosis. The company was founded by Matthew A. Cooper and Luke O'Neill in 2016 and is headquartered in Dublin, Ireland. | 8 years |
| Cathal Friel | M | 59 | 4 years | |
| Jeremy Skillington | M | 53 | 3 years | |
| Eddie Gibson | M | 50 | 3 years | |
| Ian O'Connell | M | 37 | 3 years | |
| Brendan Buckley | M | 73 | 1 years | |
| Dhavalkumar Patel | M | 63 |
Inflazome Ltd.
Inflazome Ltd. Pharmaceuticals: MajorHealth Technology Inflazome Ltd. engages in developing therapeutic medicines for inflammatory diseases. It manufactures and supplies medicines for muckle wells, type 2 diabetes, atherosclerosis, hypertension, gout, osteoarthritis, rheumatoid arthritis, Parkinson, Alzheimer, and multiple sclerosis. The company was founded by Matthew A. Cooper and Luke O'Neill in 2016 and is headquartered in Dublin, Ireland. | - |
| Bengt Westermark | M | 79 |
European Molecular Biology Organization
| - |
| Peter Denis Sutherland | M | 78 |
Royal Irish Academy
| - |
| Paul Schulze Lefert | M | - |
European Molecular Biology Organization
| - |
| Dirk Heinz | M | - |
European Molecular Biology Organization
| 15 years |
| Ross Crockett | M | - | 3 years | |
| Hermona Soreq | M | - |
European Molecular Biology Organization
| - |
| Antonio Lanzavecchia | M | 73 |
European Molecular Biology Organization
| - |
| Fulvio Mavilio | M | - |
European Molecular Biology Organization
| - |
| Michael Owen | M | 73 |
European Molecular Biology Organization
| - |
| Alan Ashworth | M | 63 |
European Molecular Biology Organization
| - |
| David Allmond | M | 54 | 1 years | |
| Karen Vousden | M | 66 |
European Molecular Biology Organization
| - |
| John McEvoy | M | 37 | - | |
| Hong Wu | M | 66 |
European Molecular Biology Organization
| 8 years |
| Bruno Speder | M | - | 2 years | |
| Carol Dalton | F | - | 3 years | |
| Carl-Hendrik Heldin | M | 72 |
European Molecular Biology Organization
| 8 years |
| Stephen Philip Jackson | M | - |
European Molecular Biology Organization
| 27 years |
| Raymond Kaempfer | M | - |
European Molecular Biology Organization
| - |
| Florent Gros | M | 56 |
Inflazome Ltd.
Inflazome Ltd. Pharmaceuticals: MajorHealth Technology Inflazome Ltd. engages in developing therapeutic medicines for inflammatory diseases. It manufactures and supplies medicines for muckle wells, type 2 diabetes, atherosclerosis, hypertension, gout, osteoarthritis, rheumatoid arthritis, Parkinson, Alzheimer, and multiple sclerosis. The company was founded by Matthew A. Cooper and Luke O'Neill in 2016 and is headquartered in Dublin, Ireland. | - |
| Hans Lennart Rudolf Wigzell | M | 86 |
European Molecular Biology Organization
| - |
| Joseph P. Schlessinger | M | 79 |
European Molecular Biology Organization
| - |
| Patrick Baeuerle | M | 66 |
European Molecular Biology Organization
| - |
| J. Kenneth Charles Knowles | M | 77 |
European Molecular Biology Organization
| - |
| Erkki Ruoslahti | M | 84 |
European Molecular Biology Organization
| - |
| Edward N. Brody | M | - |
European Molecular Biology Organization
| - |
| Daniel L. Farkas | M | 70 |
European Molecular Biology Organization
| - |
| Robert Kamen | M | 79 |
European Molecular Biology Organization
| 48 years |
| Peter J. Gregson | M | 66 |
Royal Irish Academy
| - |
| David Glover | M | - |
European Molecular Biology Organization
| - |
| Ruth Arnon | M | 91 |
European Molecular Biology Organization
| - |
| Yigong Shi | M | 57 |
European Molecular Biology Organization
| - |
| Peter Ratcliffe | M | 69 |
European Molecular Biology Organization
| - |
| Manus Rogan | M | 55 |
Inflazome Ltd.
Inflazome Ltd. Pharmaceuticals: MajorHealth Technology Inflazome Ltd. engages in developing therapeutic medicines for inflammatory diseases. It manufactures and supplies medicines for muckle wells, type 2 diabetes, atherosclerosis, hypertension, gout, osteoarthritis, rheumatoid arthritis, Parkinson, Alzheimer, and multiple sclerosis. The company was founded by Matthew A. Cooper and Luke O'Neill in 2016 and is headquartered in Dublin, Ireland. | - |
| Laurence Harris Pearl | M | - |
European Molecular Biology Organization
| - |
| Spyridon Artavanis-Tsakonas | M | 77 |
European Molecular Biology Organization
| - |
| Ashok Venkitaraman | M | - |
European Molecular Biology Organization
| - |
| Kingston H. G. Mills | M | - |
Royal Irish Academy
| - |
| John Mattick | M | - |
European Molecular Biology Organization
| - |
| Laura Maher | F | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| David Hirsch | M | 53 |
Inflazome Ltd.
Inflazome Ltd. Pharmaceuticals: MajorHealth Technology Inflazome Ltd. engages in developing therapeutic medicines for inflammatory diseases. It manufactures and supplies medicines for muckle wells, type 2 diabetes, atherosclerosis, hypertension, gout, osteoarthritis, rheumatoid arthritis, Parkinson, Alzheimer, and multiple sclerosis. The company was founded by Matthew A. Cooper and Luke O'Neill in 2016 and is headquartered in Dublin, Ireland. | 2 years |
| Frank Gannon | M | - |
European Molecular Biology Organization
| - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Germany | 30 | 61.22% |
| United Kingdom | 11 | 22.45% |
| Ireland | 8 | 16.33% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Luke O'Neill
- Personal Network
